Product Information
KAPSPARGO SPRINKLE 100 MG CAP is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $2.2928 per EA under NDC 10631001030. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jan 26, 2018.
The High Outlier badge above means this manufacturer's average price in the Metoprolol Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631001030
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA210428FDA Approved
1/26/2018
On Market Since
3/15/2018
Pharmacological Classes
Price Statistics
The NADAC for KAPSPARGO SPRINKLE 100 MG CAP has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2928 per EA |
|---|---|
| All-time high | $2.2928 (Sep 30, 2026) |
| All-time low | $2.1041 (Feb 19, 2025) |
| 52-week high | $2.2928 |
| 52-week low | $2.2016 |
| Median price | $2.2024 |
| Average price | $2.1836 |
| Largest weekly change | +5.0% (Apr 9, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metoprolol Succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KAPSPARGO SPRINKLE 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for KAPSPARGO SPRINKLE 100 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $2.2928 per EA (NDC 10631001030), effective Sep 30, 2026.
How has the price of KAPSPARGO SPRINKLE 100 MG CAP changed over time?
Over the history we have for it, the NADAC for KAPSPARGO SPRINKLE 100 MG CAP has risen 9.0%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for KAPSPARGO SPRINKLE 100 MG CAP?
Since Apr 17, 2024, the NADAC for KAPSPARGO SPRINKLE 100 MG CAP has ranged from a low of $2.1041 (Feb 19, 2025) to a high of $2.2928 (Sep 30, 2026), with a median of $2.2024 per EA.
Are there cheaper alternatives to KAPSPARGO SPRINKLE 100 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of KAPSPARGO SPRINKLE 100 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KAPSPARGO SPRINKLE 100 MG CAP?
KAPSPARGO SPRINKLE 100 MG CAP (NDC 10631001030) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.